SCHEMBL18385134

SCHEMBL18385134

CC1(C)c2ccccc2-c2ccc(-n3c4ccccc4c4ccc(-c5ccc6c7ccc(-c8ccc9c%10ccccc%10n(-c%10ccc%11c(c%10)C(C)(C)c%10ccccc%10-%11)c9c8)cc7n(-c7ccc(-c8nc(-c9ccccc9)cc(-c9ccc(-c%10ccccc%10)cc9)n8)cc7)c6c5)cc43)cc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 7/20 0.34
▸ KMT2A Q03164 7/20 0.34
▸ HPGD P15428 7/20 0.34
▸ ALDH1A1 P00352 6/20 0.34
▸ MAPT P10636 6/20 0.34
▸ NTSR1 P30989 1/20 0.34
▸ PDK2 Q15119 1/20 0.33
▸ KDM4E B2RXH2 5/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ ATM Q13315 1/20 0.33
▸ HDAC4 P56524 1/20 0.32
▸ RXRA P19793 2/20 0.32
▸ RXRB P28702 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ LMNA P02545 1/20 0.31
▸ GLA P06280 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18385140 1.00 MEN1 (0.34) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL18385130 1.00 MEN1 (0.34) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL18385128 0.99 MEN1 (0.34) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL18385138 0.97 MEN1 (0.32) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL18385153 0.97 MEN1 (0.32) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL18385132 0.97 MEN1 (0.32) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL18385164 0.97 MEN1 (0.32) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL18385146 0.97 MEN1 (0.32) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL18385647 0.97 KDM4E (0.32) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL18385192 0.96 MEN1 (0.33) MEN1KMT2AHPGDALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170018719-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-01-19 — — US disclosed
US-20170018719-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-01-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170018719-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE CD99, BMI1, ETV6 MEN1 1228/4885KMT2A 1047/4885HPGD 3186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback